177 related articles for article (PubMed ID: 29125417)
1. Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regeneration.
Kang KS; Lastfogel J; Ackerman LL; Jea A; Robling AG; Tholpady SS
J Neurosurg; 2018 Oct; 129(4):1085-1091. PubMed ID: 29125417
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formation.
Nakamura K; Koide M; Kobayashi Y; Yamashita T; Matsushita M; Yasuda H; Ishihara Y; Yoshinari N; Udagawa N
J Periodontal Res; 2023 Aug; 58(4):769-779. PubMed ID: 37154419
[TBL] [Abstract][Full Text] [Related]
3. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
[TBL] [Abstract][Full Text] [Related]
4. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
[TBL] [Abstract][Full Text] [Related]
5. Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.
Lau KH; Baylink DJ; Zhou XD; Rodriguez D; Bonewald LF; Li Z; Ruffoni D; Müller R; Kesavan C; Sheng MH
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E271-81. PubMed ID: 23715728
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
Ryan ZC; Ketha H; McNulty MS; McGee-Lawrence M; Craig TA; Grande JP; Westendorf JJ; Singh RJ; Kumar R
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6199-204. PubMed ID: 23530237
[TBL] [Abstract][Full Text] [Related]
7. Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.
Li C; Ominsky MS; Tan HL; Barrero M; Niu QT; Asuncion FJ; Lee E; Liu M; Simonet WS; Paszty C; Ke HZ
Bone; 2011 Dec; 49(6):1178-85. PubMed ID: 21890008
[TBL] [Abstract][Full Text] [Related]
8. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
Qin W; Zhao W; Li X; Peng Y; Harlow LM; Li J; Qin Y; Pan J; Wu Y; Ran L; Ke HZ; Cardozo CP; Bauman WA
Osteoporos Int; 2016 Dec; 27(12):3627-3636. PubMed ID: 27436301
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
10. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
[TBL] [Abstract][Full Text] [Related]
12. Loading-Induced Reduction in Sclerostin as a Mechanism of Subchondral Bone Plate Sclerosis in Mouse Knee Joints During Late-Stage Osteoarthritis.
Jia H; Ma X; Wei Y; Tong W; Tower RJ; Chandra A; Wang L; Sun Z; Yang Z; Badar F; Zhang K; Tseng WJ; Kramer I; Kneissel M; Xia Y; Liu XS; Wang JHC; Han L; Enomoto-Iwamoto M; Qin L
Arthritis Rheumatol; 2018 Feb; 70(2):230-241. PubMed ID: 29024567
[TBL] [Abstract][Full Text] [Related]
13. Sost, independent of the non-coding enhancer ECR5, is required for bone mechanoadaptation.
Robling AG; Kang KS; Bullock WA; Foster WH; Murugesh D; Loots GG; Genetos DC
Bone; 2016 Nov; 92():180-188. PubMed ID: 27601226
[TBL] [Abstract][Full Text] [Related]
14. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
[TBL] [Abstract][Full Text] [Related]
15.
Albiol L; Cilla M; Pflanz D; Kramer I; Kneissel M; Duda GN; Willie BM; Checa S
J R Soc Interface; 2018 Apr; 15(141):. PubMed ID: 29669893
[TBL] [Abstract][Full Text] [Related]
16. Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways.
Bouaziz W; Funck-Brentano T; Lin H; Marty C; Ea HK; Hay E; Cohen-Solal M
Arthritis Res Ther; 2015 Feb; 17(1):24. PubMed ID: 25656376
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous ossification.
McGee-Lawrence ME; Ryan ZC; Carpio LR; Kakar S; Westendorf JJ; Kumar R
Biochem Biophys Res Commun; 2013 Nov; 441(4):886-90. PubMed ID: 24211207
[TBL] [Abstract][Full Text] [Related]
18. Bone and suture regeneration in calvarial defects by e-PTFE-membranes and demineralized bone matrix and the impact on calvarial growth: an experimental study in the rat.
Mardas N; Kostopoulos L; Karring T
J Craniofac Surg; 2002 May; 13(3):453-62; discussion 462-4. PubMed ID: 12040218
[TBL] [Abstract][Full Text] [Related]
19. Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.
Yang H; Büttner A; Albiol L; Julien C; Thiele T; Figge C; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
Sci Rep; 2020 Dec; 10(1):22299. PubMed ID: 33339872
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
Li C; Wang W; Xie L; Luo X; Cao X; Wan M
Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
